Skip to main content

RHUMBLINE ADVISERS

Position in HROW — Harrow, Inc.

CIK 1115418 BOSTON, MA

Position in HROW

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$1,311,319
-$526,426 QoQ
Shares Held
37,190
-0.8% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 21.320247378327508.ToString("F0")% Shared 0.ToString("F0")% None 78.67975262167249.ToString("F0")%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. HROW ranks #25 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HROW

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,311,319 37,190
2025-12-31 $1,837,745 37,505
2025-09-30 $2,206,306 45,793
2025-06-30 $1,434,433 46,969
2025-03-31 $1,143,135 42,975
2024-12-31 $1,345,220 40,096
2024-09-30 $1,844,573 41,027
2024-06-30 $898,708 43,021
2024-03-31 $526,130 39,768
2023-12-31 $431,076 38,489
2023-09-30 $587,244 40,866
2023-06-30 $638,963 33,559
2021-03-31 $108,870 16,129
2020-12-31 $114,692 16,719
2020-09-30 $84,291 15,079
2020-06-30 $98,724 18,949